114 related articles for article (PubMed ID: 23291367)
1. The association between cystatin C and incident type 2 diabetes is related to central adiposity.
Reutens AT; Bonnet F; Lantieri O; Roussel R; Balkau B;
Nephrol Dial Transplant; 2013 Jul; 28(7):1820-9. PubMed ID: 23291367
[TBL] [Abstract][Full Text] [Related]
2. Insulin resistance and inflammation may have an additional role in the link between cystatin C and cardiovascular disease in type 2 diabetes mellitus patients.
Lee SH; Park SA; Ko SH; Yim HW; Ahn YB; Yoon KH; Cha BY; Son HY; Kwon HS
Metabolism; 2010 Feb; 59(2):241-6. PubMed ID: 19765773
[TBL] [Abstract][Full Text] [Related]
3. High levels of cystatin C predict the metabolic syndrome: the prospective Malmö Diet and Cancer Study.
Magnusson M; Hedblad B; Engström G; Persson M; Nilsson P; Melander O
J Intern Med; 2013 Aug; 274(2):192-9. PubMed ID: 23414447
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of glycemia, body size, insulin resistance and the risk of hypertension in Mauritius.
Boyko EJ; Shaw JE; Zimmet PZ; Chitson P; Tuomilehto J; Alberti KG
J Hypertens; 2008 Sep; 26(9):1742-9. PubMed ID: 18698207
[TBL] [Abstract][Full Text] [Related]
5. Modification of Association of Cystatin C With Kidney and Cardiovascular Outcomes by Obesity.
Chen DC; Scherzer R; Ix JH; Kramer HJ; Crews DC; Nadkarni G; Gutierrez O; Bullen AL; Ilori T; Garimella PS; Shlipak MG; Estrella MM
Am J Kidney Dis; 2024 Apr; 83(4):489-496.e1. PubMed ID: 37866793
[TBL] [Abstract][Full Text] [Related]
6. Three-year increase of gamma-glutamyltransferase level and development of type 2 diabetes in middle-aged men and women: the D.E.S.I.R. cohort.
André P; Balkau B; Born C; Charles MA; Eschwège E;
Diabetologia; 2006 Nov; 49(11):2599-603. PubMed ID: 16969645
[TBL] [Abstract][Full Text] [Related]
7. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity.
Wexler DJ; Hu FB; Manson JE; Rifai N; Meigs JB
Obes Res; 2005 Oct; 13(10):1772-83. PubMed ID: 16286525
[TBL] [Abstract][Full Text] [Related]
8. Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease: the DESIR study.
Tapp RJ; Balkau B; Shaw JE; Valensi P; Cailleau M; Eschwege E;
Atherosclerosis; 2007 Jan; 190(1):84-9. PubMed ID: 16674960
[TBL] [Abstract][Full Text] [Related]
9. Adiposity and incident diabetes within 4 years of follow-up: the Guangzhou Biobank Cohort Study.
Xu L; Lam TH; Jiang CQ; Zhang WS; Jin YL; Zhu T; Zhu F; Thomas GN; Cheng KK
Diabet Med; 2017 Oct; 34(10):1400-1406. PubMed ID: 28477424
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD36 (sCD36) clusters with markers of insulin resistance, and high sCD36 is associated with increased type 2 diabetes risk.
Handberg A; Norberg M; Stenlund H; Hallmans G; Attermann J; Eriksson JW
J Clin Endocrinol Metab; 2010 Apr; 95(4):1939-46. PubMed ID: 20139232
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
12. Elevated cystatin C concentration and progression to pre-diabetes: the Western New York study.
Donahue RP; Stranges S; Rejman K; Rafalson LB; Dmochowski J; Trevisan M
Diabetes Care; 2007 Jul; 30(7):1724-9. PubMed ID: 17456840
[TBL] [Abstract][Full Text] [Related]
13. Maternal waist circumference and the prediction of children's metabolic syndrome.
Hirschler V; Roque MI; Calcagno ML; Gonzalez C; Aranda C
Arch Pediatr Adolesc Med; 2007 Dec; 161(12):1205-10. PubMed ID: 18056567
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in obese Thai children and adolescents.
Iamopas O; Chongviriyaphan N; Suthutvoravut U
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S126-32. PubMed ID: 22043765
[TBL] [Abstract][Full Text] [Related]
15. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study.
Snijder MB; Heine RJ; Seidell JC; Bouter LM; Stehouwer CD; Nijpels G; Funahashi T; Matsuzawa Y; Shimomura I; Dekker JM
Diabetes Care; 2006 Nov; 29(11):2498-503. PubMed ID: 17065691
[TBL] [Abstract][Full Text] [Related]
16. Impaired fasting glucose, ancestry and waist-to-height ratio: main predictors of incident diagnosed diabetes in the Canary Islands.
de León AC; Coello SD; González DA; Díaz BB; Rodríguez JC; Hernández AG; Aguirre-Jaime A; Pérez Mdel C
Diabet Med; 2012 Mar; 29(3):399-403. PubMed ID: 21883429
[TBL] [Abstract][Full Text] [Related]
17. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
18. Prescreening tools for diabetes and obesity-associated dyslipidaemia: comparing BMI, waist and waist hip ratio. The D.E.S.I.R. Study.
Balkau B; Sapinho D; Petrella A; Mhamdi L; Cailleau M; Arondel D; Charles MA;
Eur J Clin Nutr; 2006 Mar; 60(3):295-304. PubMed ID: 16278693
[TBL] [Abstract][Full Text] [Related]
19. Impact of hip circumference and height on incident diabetes: results from 6-year follow-up in the Tehran Lipid and Glucose Study.
Bozorgmanesh M; Hadaegh F; Zabetian A; Azizi F
Diabet Med; 2011 Nov; 28(11):1330-6. PubMed ID: 21627688
[TBL] [Abstract][Full Text] [Related]
20. Disability in patients with multiple sclerosis: influence of insulin resistance, adiposity, and oxidative stress.
Oliveira SR; Simão AN; Kallaur AP; de Almeida ER; Morimoto HK; Lopes J; Dichi I; Kaimen-Maciel DR; Reiche EM
Nutrition; 2014 Mar; 30(3):268-73. PubMed ID: 24484677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
